Navigation Links
Boehringer Ingelheim and Lilly's new oral type 2 diabetes treatment for adults, Jentadueto™ (linagliptin/metformin hydrochloride) tablets, now available in U.S. pharmacies
Date:3/7/2012

dicines and information – for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.

About Lilly Diabetes
For more than 85 years, Lilly has been a worldwide leader in pioneering industry-leading solutions to support people living with and treating diabetes. Lilly introduced the world's first commercial insulin in 1923, and remains at the forefront of medical and delivery device innovation to manage diabetes. Lilly is also committed to providing solutions beyond therapy – practical tools, education, and support programs to help overcome barriers to success along the diabetes journey. At Lilly, the journeys of each person living with or treating diabetes inspire ours. For more information, visit www.lillydiabetes.com.

This press release contains forward-looking statements about JENTADUETO for the treatment of type 2 diabetes. It reflects Lilly's current beliefs; however, as with any such undertaking, there are substantial risks and uncertainties in the process of drug development and commercialization. There is no guarantee that future study results and patient experience will be consistent with study findings to date or that JENTADUETO will be commercially successful. For further discussion of these and other risks and uncertainties, please see Lilly's latest Forms 10-Q and 10-K filed with the U.S. Securities and Exchange Commission. Lilly undertakes no duty to update forward-looking statements.

P-LLY

JD184300 PR

(1) Centers for Disease Control and Prevention. National Diabetes Fact Sheet 2011. http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf. Accessed on: February 22, 2012.

(2) International Diabetes Federation. Diabetes Atlas, 5th Edition: Fact Sheet. 2011.

(3) Internation
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Boehringer Ingelheim Initiates NEwArT Study Comparing Viramune(R) (nevirapine) to a Ritonavir-Boosted Atazanavir-based Regimen in Treatment-Naive HIV Patients
2. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
3. Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009
4. Boehringer Ingelheim Unveils Diabetes Pipeline
5. Boehringer Ingelheim Animal Health Closes Deal to Acquire a Significant Portion of the Fort Dodge Animal Health Business From Pfizer
6. Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile
7. New Boehringer Ingelheim Science Quest Mobile Laboratory Brings Hands-On Science Education to Priority Connecticut Elementary Schools
8. Boehringer Ingelheim Affirms Safety of Telmisartan With an Analysis of 50,000 Patients and Strongly Disagrees With the Publication of Sipahi et al in Lancet Oncology June 2010
9. -- Neurocrine Announces a Second Corporate Collaboration Within Twenty-Four Hours -- Neurocrine Biosciences Announces a Worldwide Collaboration With Boehringer Ingelheim to Research and Develop GPR119 Agonists for Type II Diabetes
10. Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes
11. Boehringer Ingelheim and MacroGenics Announce Global Alliance to Discover, Develop and Commercialize DART™-Based Antibody Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... , Sept. 3, 2015  Ascendis Pharma ... stage biotechnology company that applies its innovative ... needs, today announced plans to present at ... Fargo Healthcare Conference in BostonDate: , Thursday, ... Bank of America Merrill Lynch Global Healthcare ...
(Date:9/3/2015)... Research and Markets( http://www.researchandmarkets.com/research/fw4ctl/investigation ) has ... China,s Entecavir Market, 2010-2019" report to their offering. ... B virus (HBV) exceeds 100 million in ... chronic Hepatitis B. About 0.5 million Chinese is estimated ... by chronic Hepatitis B, causing a loss of over ...
(Date:9/3/2015)... CITY, Calif. , Sept. 3, 2015  Abaxis, ... manufacturing point-of-care blood instrumentation and consumables to the medical, ... Taylor , chief financial officer, will present at the ... 2015 on Thursday, September 10, 2015 at 11:00 a.m. ... Berkshire Place Hotel in New York City ...
Breaking Medicine Technology:Ascendis Pharma A/S to Present at Three Upcoming Investor Conferences 2China Entecavir Market Report 2010-2019 2
... -- Precision Antibody™ announced today its selection by the United ... to influenza virus antigens for both Influenza A and B. ... develop new vaccine potency assays. The term of the monoclonal ... the option of five additional years. On ...
... Robertson Global Health Solutions Corporation (OTCBB: RHSC) and ... they have signed a commercial agreement with Telemedicine Africa ... and solutions to the medically underserved population of Africa ... and Telemedicine Africa aim to deliver RHealth Advisor mobile ...
Cached Medicine Technology:FDA Awards Precision Antibody Contract to Develop Monoclonal Antibodies for Influenza Vaccine Potency Assays 2FDA Awards Precision Antibody Contract to Develop Monoclonal Antibodies for Influenza Vaccine Potency Assays 3Robertson Global Health Solutions Announces Commercial Venture with Telemedicine Africa 2Robertson Global Health Solutions Announces Commercial Venture with Telemedicine Africa 3Robertson Global Health Solutions Announces Commercial Venture with Telemedicine Africa 4
(Date:9/3/2015)... ... September 03, 2015 , ... E-Volve Health, ... leading national healthcare solutions organization, to provide electronic medical record (EMR) consulting services ... Amerinet members will receive negotiated pricing on E-Volve Health’s Epic EMR consulting, custom ...
(Date:9/3/2015)... ... September 03, 2015 , ... BedJet released a new version of its award ... Kickstarter. Today the BedJet v2 pre-order campaign blazed past the $1 million ... campaigns ever on crowdfunding giant Kickstarter. , Simple to use and beautifully designed, the ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... Companies to Watch for 2015 by economic development group GrowFL and the ... companies in the state selected for this prestigious award, which recognizes growing second-stage ...
(Date:9/3/2015)... ... 03, 2015 , ... The first part of a two-part investigative news segment ... filter lawsuits filed against Bard.** These lawsuits, filed by persons and the family ... or failed, have recently been consolidated for pretrial proceedings as multidistrict litigation, MDL 2641 ...
(Date:9/3/2015)... ... September 03, 2015 , ... B. E. ... been retained to lead a national chief executive officer recruitment for ... in the healthcare industry, B. E. Smith has recently placed more than 1,000 ...
Breaking Medicine News(10 mins):Health News:E-Volve Health to Offer EMR Consulting Solutions to Amerinet Members 2Health News:BedJet Hits $1 million in Sales in 28 Days on Kickstarter after Shark Tank Rejection 2Health News:BedJet Hits $1 million in Sales in 28 Days on Kickstarter after Shark Tank Rejection 3Health News:IQ Formulations Hailed Among Florida Companies to Watch for 2015 2Health News:IQ Formulations Hailed Among Florida Companies to Watch for 2015 3Health News:Bard IVC Lawsuit Allegations Reach National Prime Time News 2Health News:Bard IVC Lawsuit Allegations Reach National Prime Time News 3Health News:Melissa Memorial Hospital Retains B. E. Smith to Recruit New CEO 2Health News:Melissa Memorial Hospital Retains B. E. Smith to Recruit New CEO 3
... ... that special woman who has everything? Why stem cells, of course! Celebrity Beauty Engineer® ... how to look and feel their best! , ... (PRWEB) December 16, 2009 -- The holidays are rapidly approaching and what ...
... , WASHINGTON, Dec. 15 ... prescription drugs to cut costs, much less the more effective direct ... how big industry controls the health reform debate, according Consumer Watchdog. ... relatively modest proposal, far from President Obama,s campaign pledge to allow ...
... WASHINGTON, Dec. 15 The Food and Health Bureau has invited ... developing private hospitals at four sites in the Hong Kong Special ... , At a press conference, the Secretary for Food and ... was one of the initiatives under healthcare reform and a major ...
... , WASHINGTON, Dec. 15 Our Lady of Lourdes ... Jersey hospitals, has agreed to pay the United States $7.95 ... Justice Department announced today. The two hospitals are Our Lady ... Medical Center of Burlington County (LMC) in Willingboro, N.J. ...
... would have really been in trouble, expert says , TUESDAY, ... H1N1 swine flu has revealed serious flaws in the nation,s ... says. , The report, prepared by the Trust for America,s ... dire economy has strained the already underfunded public health system. ...
... , , ... the fight against malaria , Project developed with support ... , WASHINGTON, Dec. 15 ONE and Malaria ... "Malaria Griots" program, a dynamic education course that will train and ...
Cached Medicine News:Health News:New Online Beauty Store Suggests Stem Cells for the Woman Who Has Everything 2Health News:Failure of Drug Importation Amendment in U.S. Senate is Latest Show of Industry's Controlling Hand in Health Reform Debate, According to Consumer Watchdog 2Health News:Failure of Drug Importation Amendment in U.S. Senate is Latest Show of Industry's Controlling Hand in Health Reform Debate, According to Consumer Watchdog 3Health News:Hong Kong Government Invites Expressions of Interest in Development of Private Hospitals 2Health News:Parent Company of Two New Jersey Hospitals to Pay U.S. $7.95 Million to Settle False Claims Act Allegations 2Health News:Serious Gaps Revealed in U.S. Response to Health Emergencies 2Health News:Serious Gaps Revealed in U.S. Response to Health Emergencies 3Health News:ONE and Malaria No More Launch 'Malaria Griots' 2Health News:ONE and Malaria No More Launch 'Malaria Griots' 3Health News:ONE and Malaria No More Launch 'Malaria Griots' 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: